FineMark National Bank & Trust’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,091
Closed -$206K 455
2024
Q4
$206K Buy
6,091
+240
+4% +$8.12K 0.01% 407
2024
Q3
$239K Buy
+5,851
New +$239K 0.01% 378
2024
Q2
Sell
-4,777
Closed -$205K 438
2024
Q1
$205K Buy
+4,777
New +$205K 0.01% 404
2023
Q3
Sell
-5,811
Closed -$207K 422
2023
Q2
$207K Sell
5,811
-108
-2% -$3.85K 0.01% 401
2023
Q1
$211K Sell
5,919
-68
-1% -$2.42K 0.01% 388
2022
Q4
$210K Buy
+5,987
New +$210K 0.01% 380
2022
Q3
Sell
-4,827
Closed -$263K 399
2022
Q2
$263K Sell
4,827
-3
-0.1% -$163 0.01% 355
2022
Q1
$263K Hold
4,830
0.01% 386
2021
Q4
$266K Sell
4,830
-512
-10% -$28.2K 0.01% 399
2021
Q3
$255K Sell
5,342
-2,186
-29% -$104K 0.01% 389
2021
Q2
$375K Sell
7,528
-386
-5% -$19.2K 0.02% 331
2021
Q1
$353K Buy
7,914
+216
+3% +$9.64K 0.01% 326
2020
Q4
$354K Buy
7,698
+2,026
+36% +$93.2K 0.02% 310
2020
Q3
$267K Sell
5,672
-156
-3% -$7.34K 0.01% 318
2020
Q2
$297K Hold
5,828
0.02% 298
2020
Q1
$276K Hold
5,828
0.02% 280
2019
Q4
$342K Sell
5,828
-440
-7% -$25.8K 0.02% 293
2019
Q3
$334K Buy
6,268
+341
+6% +$18.2K 0.02% 286
2019
Q2
$297K Buy
5,927
+802
+16% +$40.2K 0.02% 296
2019
Q1
$268K Sell
5,125
-513
-9% -$26.8K 0.02% 291
2018
Q4
$269K Buy
5,638
+286
+5% +$13.6K 0.02% 285
2018
Q3
$269K Buy
+5,352
New +$269K 0.02% 270
2015
Q4
Sell
-14,212
Closed -$683K 1406
2015
Q3
$683K Sell
14,212
-526
-4% -$25.3K 0.09% 166
2015
Q2
$767K Buy
14,738
+328
+2% +$17.1K 0.1% 173
2015
Q1
$831K Sell
14,410
-1,025
-7% -$59.1K 0.11% 164
2014
Q4
$825K Buy
15,435
+1,589
+11% +$84.9K 0.12% 159
2014
Q3
$795K Buy
13,846
+1,023
+8% +$58.7K 0.13% 153
2014
Q2
$857K Sell
12,823
-526
-4% -$35.2K 0.14% 146
2014
Q1
$891K Buy
13,349
+2,377
+22% +$159K 0.17% 137
2013
Q4
$732K Buy
10,972
+798
+8% +$53.2K 0.15% 144
2013
Q3
$639K Sell
10,174
-658
-6% -$41.3K 0.16% 136
2013
Q2
$682K Buy
+10,832
New +$682K 0.21% 101